Related Experiment Videos
Transient neonatal diabetes mellitus. Treatment with chlorpropamide
American Journal of Diseases of Children (1960)
|January 1, 1979
Insights
Transient neonatal diabetes mellitus was observed in a small-for-dates infant. Chlorpropamide effectively managed the condition, suggesting its potential use in treating temporary neonatal diabetes.
Area of Science:
- Neonatology
- Endocrinology
- Pediatric Diabetes
Background:
- Neonatal diabetes mellitus (NDM) is a rare condition characterized by hyperglycemia presenting within the first few months of life.
- Transient NDM (TNDM) typically resolves within weeks or months, distinguishing it from permanent NDM.
- Small-for-dates infants represent a specific demographic with potential unique metabolic challenges.
Observation:
- A neonate, identified as small-for-dates, developed nonketotic diabetes mellitus at 6 days of age.
- Initial management involved insulin therapy to control blood glucose levels.
- A transition to chlorpropamide therapy was initiated at 40 days of age, gradually replacing insulin over 24 days.
Findings:
- Chlorpropamide treatment successfully controlled the infant's diabetes mellitus.
- The infant remained clinically well after the cessation of all diabetes treatment at 13 weeks of age.
- This case suggests a potential therapeutic role for chlorpropamide in TNDM.
Implications:
- Chlorpropamide may be a viable treatment option for transient neonatal diabetes mellitus.
- Further research is warranted to explore the efficacy and safety of chlorpropamide in larger cohorts of infants with TNDM.
- Understanding the mechanisms behind chlorpropamide's effectiveness in TNDM could inform future therapeutic strategies for neonatal hyperglycemia.
Abstract:
Nonketotic diabetes mellitus developed in a "small-for-dates" baby at the age of 6 days. The disease was controlled initially with insulin but beginning at the age of 40 days, chlorpropamide was substituted gradually for insulin over a 24-day period. Treatment was stopped at the age of 13 weeks and the baby remained well thereafter. It is suggested that chlorpropamide might be useful in the treatment of transient neonatal diabetes.